Offer - Urjas Oil for just ₹ 1 X
Soliact 5 Tablet (15) is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Urinary Incontinence. Secondary and off-label uses of Soliact 5 Tablet (15) have also been mentioned below.
The optimal dosage of Soliact 5 Tablet (15) is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Some other side effects of Soliact 5 Tablet (15) have been listed ahead. These side effects of Soliact 5 Tablet (15) are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Soliact 5 Tablet (15) is Moderate for pregnant women and Moderate for women who are breastfeeding. In addition, Soliact 5 Tablet (15)'s effects on the liver, heart and kidney are discussed below in the Soliact 5 Tablet (15) related warnings section.
Individuals suffering from medical conditions like Kidney Disease, Liver Disease must refrain from the use of Soliact 5 Tablet (15) since this can cause severe adverse effects. The section on Soliact 5 Tablet (15) contraindications lists all such conditions.
Besides this, Soliact 5 Tablet (15) may also have severe interaction with some medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Soliact 5 Tablet (15) is considered not safe while driving, and is not addictive.
Soliact 5 Tablet (15) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Soliact 5 Tablet (15) safe for pregnant women?
Soliact can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Soliact right away. Take your doctor's advice before taking it again.
Is the use of Soliact 5 Tablet (15) safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Soliact. Immediately discontinue Soliact if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Soliact 5 Tablet (15) on the Kidneys?
Soliact rarely harms the kidneys.
What is the effect of Soliact 5 Tablet (15) on the Liver?
Soliact may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Soliact 5 Tablet (15) on the Heart?
Side effects of Soliact rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Soliact 5 Tablet (15) unless your doctor advises you to do so -
Is this Soliact 5 Tablet (15) habit forming or addictive?
No, you will not get addicted to Soliact 5 Tablet (15).
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Soliact 5 Tablet (15). So it is best to avoid driving.
Is it safe?
Soliact 5 Tablet (15) should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Soliact 5 Tablet (15) in mental disorders is not effective.
Interaction between Food and Soliact 5 Tablet (15)
Taking Soliact 5 Tablet (15) with food does not cause any problems.
Interaction between Alcohol and Soliact 5 Tablet (15)
Consult your doctor before consuming alcohol while taking Soliact 5 Tablet (15) as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; VESIcare® (solifenacin succinate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1151